NeuBase Therapeutics, Inc. SC 13G and SC 13G/A reports

Location
350 Technology Drive, Pittsburgh, PA
State of incorporation
DE
Fiscal year end
December 31
Data updated at
7/19/2024, 09:11 AM
Form type Sec Links Description Filing date Reporting date
SC 13G/A Report AMENDMENT NO. 3 Feb 14, 2024
SC 13G/A Report KTA NBSE 13G AMEND Jan 27, 2023
SC 13G/A Report AMENDMENT NO. 2 Feb 14, 2022
SC 13G/A Report AMENDMENT NO. 1 Feb 16, 2021
SC 13G/A Report KTA NBSE SC 13G Dec 29, 2020
SC 13G/A Report AMENDMENT TO FORM SC 13G May 1, 2020
SC 13G Report NEUBASE THERAPEUTICS - TITCOMB TRUST 13G Aug 27, 2019
SC 13G Report SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP Jul 22, 2019
SC 13G Report SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP Jul 22, 2019
SC 13G Report SC 13G FILING OHRP Jul 18, 2019
SC 13G Report Jul 16, 2019
SC 13G/A Report AMENDMENT TO FORM SC 13G Feb 15, 2018
SC 13G/A Report AMENDMENT TO FORM SC 13G/A Feb 15, 2017
SC 13G/A Report Feb 16, 2016
SC 13G/A Report Feb 12, 2016
SC 13G Report Apr 7, 2015
SC 13G/A Report SC 13G/A Feb 13, 2015
SC 13G Report SCHEDULE 13G Jul 11, 2014
SC 13G Report ACQUISITION OF EQUITY OWNERSHIP Mar 24, 2014
SC 13G/A Report AMENDMENT TO FORM SC 13G Feb 21, 2014
SC 13G/A Report SCHEDULE 13G/A Feb 14, 2014
SC 13G Report Feb 14, 2014
SC 13G Report Feb 14, 2014
SC 13G Report Feb 13, 2014
SC 13G Report Feb 13, 2014
SC 13G Report SCHEDULE 13G Jun 28, 2013